On April 25, 2019, the Zhongguancun Administrative Committee, along with other organizations, hosted the "Zhongguancun New Medical Technology and Product Supply-Demand Matchmaking Conference" at the China National Institute for Food and Drug Control's report hall. The theme was "Leveraging Zhongguancun's Advantages to Accelerate the Development of the Capital's Medical and Health Industry."
Beijing Novel Medical Equipment Co., Ltd. showcased its self-developed Variable Angle Dual-Head SPECT NET632 and InliView-3000B Animal PET/SPECT/CT at the supply-demand matchmaking conference.
The NET632 SPECT is a clinical molecular imaging device with a maximum count rate of 560kcps. It can obtain data on drug absorption, distribution, and metabolism through external detection, thus reflecting the functional metabolic information of human organs or tissues and providing a basis for clinical diagnosis.
The InliView-3000B Animal PET/SPECT/CT is a tri-modality molecular imaging research device. It perfectly integrates high-performance animal molecular imaging and anatomical imaging, providing metabolic data to support medical research and drug development.
Language
